Altshuler David's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 14, 2022
- Accession no.
- 0001209191-22-009232
- Filed
- Feb 14, 2022
- Trade date
- Feb 10-11, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $539.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Altshuler DavidCIK 0001550395 | Officer (EVP, Global Research and CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2022 | Common Stock | FTax withholdingDisposed | −3,518 | $237.74 | −$836,369.32 | 62,179 | Direct | |
| Feb 11, 2022 | Common Stock | SSaleDisposed | −841 | $233.92F2,F3 | −$196,726.72 | 61,338 | Direct | |
| Feb 11, 2022 | Common Stock | SSaleDisposed | −757 | $234.95F3,F4 | −$177,857.15 | 60,581 | Direct | |
| Feb 11, 2022 | Common Stock | SSaleDisposed | −601 | $236.28F3,F5 | −$142,004.28 | 59,980 | Direct | |
| Feb 11, 2022 | Common Stock | SSaleDisposed | −98 | $237.23 | −$23,248.54 | 59,882 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Open market sales reported on this line occurred at a weighted average price of $233.92 (range $233.36 to $234.30).
Referenced by the price of 1 transaction in Table I.
- F3
Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 3 transactions in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $234.95 (range $234.47 to $235.28).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $236.28 (range $235.84 to $236.74).
Referenced by the price of 1 transaction in Table I.